BCN_RESEARCH_DRTV_2021_23.jpg

The Patricia Swannell dormancy and late recurrence research funding programme

Most breast cancers don’t return after treatment. But in some cases, cancer cells can remain inactive in the body for years before reawakening. As the UK’s largest dedicated breast cancer research funder we've already invested over £299 million in groundbreaking research. And we’re not stopping there.

We work solely on bringing together research and support to tackle breast cancer more effectively, to reduce the risk and to better support all those affected by the disease, whether directly or indirectly.

What's the purpose of this scheme?

This funding programme aims to support research addressing dormancy and late recurrence of breast cancer. It has been created thanks to the Patricia Swannell Appeal for secondary breast cancer and the incredible generosity of everyone who has supported the appeal.

Driven by a selfless passion and determination to make a difference for those who come after her, Patricia devoted the last 18 precious months of her life to driving change for people affected by secondary breast cancer. With the loving support of her family, The Patricia Swannell Appeal for Secondary Breast Cancer was set up in 2022 to:

  • Raise awareness of the signs and symptoms of secondary breast cancer
  • Support healthcare professionals with education and training
  • Develop better testing, diagnosis and treatment through funding research to tackle the challenge of dormancy

When is the next funding round?

This was a one-off funding scheme in 2024. Please have a look at our funding opportunities to learn more about our other funding rounds.

Our newly funded projects

Have any questions?

If you have any questions, please send us an email, and we'll get back to you as soon as we can.

Email us